How long does minoxidil take to work — and for how long must you keep using it?

Two questions decide whether topical minoxidil is worth starting: how soon will you see anything, and can you ever stop? The trial evidence answers both, and neither answer is a quick one. Minoxidil works on a scale of months, not weeks, and the long-term data suggest the regrowth it buys is rented, not owned — it fades when you quit.

The pivotal trials ran for months

The studies that established minoxidil's efficacy were not short. The definitive men's trial randomised 393 men aged 18 to 49 to 5% solution, 2% solution or placebo, applied twice daily, and measured hair counts out to 48 weeks [s1]. The women's noninferiority trial randomised 113 women to 5% foam once daily or 2% solution twice daily, with the primary hair-count endpoint assessed at week 24 [s2]. Those timelines — 24 and 48 weeks — are the horizon over which minoxidil was proven, and a fair guide to how long you should expect to wait before judging whether it is doing anything.

Waiting matters because of how minoxidil acts. It works by extending the growth phase of hair follicles and enlarging miniaturised ones, a process that plays out over successive hair cycles. In the men's trial, the 5% concentration was clearly superior to 2% and placebo, producing 45% more hair regrowth than 2% at week 48 — and, notably, response to treatment occurred earlier with 5% than with 2% [s1]. Earlier, not immediate: the effect still accrued over many weeks.

When it peaks

For the ceiling, the most informative data come from long-term follow-up. In a study of 31 men who completed four and a half to five years of topical minoxidil, hair regrowth tended to peak at about one year, followed by a slow decline in regrowth over the subsequent years [s3]. So the realistic arc is: little to see for the first several months, maximum benefit around the one-year mark, then a gentle tapering of the regrowth even while treatment continues [s3].

That is worth setting against the marketing, which tends to imply steady, open-ended gains. The honest picture is a curve that rises for roughly a year and then eases back — though, crucially, it does not fall to nothing. It is also why a photograph taken at three months is a poor basis for a verdict: at that point many users are still on the rising part of the curve, well short of the peak.

The two strengths differ mainly in speed and size, not in this overall shape. In the men's trial the 5% solution not only produced more regrowth than 2% but delivered it earlier, and improved patients' own psychosocial ratings of their hair loss [s1]. The cost of that extra potency was tolerability: 5% caused more pruritus and local irritation than 2% [s1] — the kind of nuisance that, over a treatment measured in years, can quietly end the very persistence the drug depends on.

Why you can't simply stop

The same five-year study is the clearest evidence on the "for how long" question. Even at four and a half to five years, the men retained more non-vellus (thick, pigmented) hairs than they had at baseline — minoxidil appeared to help maintain hair growth over the long haul [s3]. The mechanism is maintenance: the drug is holding follicles in a productive state they would otherwise be leaving.

The corollary, which every prescriber stresses, is that the benefit is contingent on continued use. Minoxidil does not cure androgenetic alopecia or alter its underlying course; it counteracts the miniaturisation for as long as it is applied. Stop, and the follicles resume the trajectory they were on, so the regrown hair is gradually lost over the following months. That is why the trials frame minoxidil as an ongoing treatment rather than a fixed course [s1][s3].

What this means in practice

Set expectations against the data. Give it at least the trial horizon — four to six months minimum, and closer to a year — before deciding whether it works for you, because that is how long the pivotal studies needed to detect and maximise their effect [s1][s2][s3]. Expect the biggest improvement around one year, then a modest settling [s3]. And treat it as indefinite: the maintained hair count at five years is the upside, but it is upside that depends on not stopping [s3].

Two practical footnotes from the trials. The 5% strength outperformed 2% in men, and worked sooner [s1]; and in women, a once-daily 5% foam matched a twice-daily 2% solution while causing significantly less itching and dandruff — a formulation that is easier to keep using, which, for a drug whose whole value rests on persistence, is not a trivial advantage [s2].

Sources

• [s1] Olsen EA, Dunlap FE, Funicella T, et al. "A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men." Journal of the American Academy of Dermatology, Sep 2002. https://doi.org/10.1067/mjd.2002.124088
• [s2] Blume-Peytavi U, Hillmann K, Dietz E, et al. "A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women." Journal of the American Academy of Dermatology, Dec 2011. https://doi.org/10.1016/j.jaad.2010.09.724
• [s3] Olsen EA, Weiner MS, Amara IA, DeLong ER. "Five-year follow-up of men with androgenetic alopecia treated with topical minoxidil." Journal of the American Academy of Dermatology, Apr
  1. https://doi.org/10.1016/0190-9622(90)70089-z